These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33044755)

  • 21. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
    Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
    J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
    Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
    Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis.
    Li S; Liang X; Ma L; Shen L; Li T; Zheng L; Sun A; Shang W; Chen C; Zhao W; Jia J
    Oncogene; 2018 Feb; 37(7):884-896. PubMed ID: 29059152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.
    Xiang T; Yuan C; Guo X; Wang H; Cai Q; Xiang Y; Luo W; Liu G
    Cell Death Dis; 2021 Feb; 12(2):150. PubMed ID: 33542225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
    Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
    Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Liu LP; Sheng XP; Shuai TK; Zhao YX; Li B; Li YM
    World J Gastroenterol; 2018 Oct; 24(40):4565-4577. PubMed ID: 30386106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation.
    Song G; Ouyang G; Mao Y; Ming Y; Bao S; Hu T
    J Cell Mol Med; 2009 Aug; 13(8B):1706-1718. PubMed ID: 19602039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential meiotic structure-specific endonuclease1 (
    Guo Z; Liang E; Li W; Jiang L; Zhi F
    Bioengineered; 2021 Dec; 12(2):9869-9884. PubMed ID: 34719326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
    Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
    Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer.
    Wang ZQ; Cai Q; Hu L; He CY; Li JF; Quan ZW; Liu BY; Li C; Zhu ZG
    Cell Death Dis; 2017 Jun; 8(6):e2839. PubMed ID: 28569779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
    Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
    Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
    Fan HN; Zhu MY; Peng SQ; Zhu JS; Zhang J; Qu GQ
    Pathol Res Pract; 2020 Feb; 216(2):152795. PubMed ID: 31879047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression.
    Akiyama Y; Koda Y; Byeon SJ; Shimada S; Nishikawaji T; Sakamoto A; Chen Y; Kojima K; Kawano T; Eishi Y; Deng D; Kim WH; Zhu WG; Yuasa Y; Tanaka S
    Oncotarget; 2016 Jan; 7(4):3966-83. PubMed ID: 26701885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capn4 contributes to tumor invasion and metastasis in gastric cancer via activation of the Wnt/β-catenin/MMP9 signalling pathways.
    Zhao C; Yuan G; Jiang Y; Xu J; Ye L; Zhan W; Wang J
    Exp Cell Res; 2020 Oct; 395(2):112220. PubMed ID: 32777225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
    Eun JW; Kim HS; Shen Q; Yang HD; Kim SY; Yoon JH; Park WS; Lee JY; Nam SW
    J Pathol; 2018 Jan; 244(1):107-119. PubMed ID: 28991363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
    Wang Y; Xie BH; Lin WH; Huang YH; Ni JY; Hu J; Cui W; Zhou J; Shen L; Xu LF; Lian F; Li HP
    Oncogene; 2019 Jun; 38(25):4948-4961. PubMed ID: 30842588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.
    Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
    Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF2α is associated with poor prognosis and affects the expression levels of survivin and cyclin D1 in gastric carcinoma.
    Tong WW; Tong GH; Chen XX; Zheng HC; Wang YZ
    Int J Oncol; 2015 Jan; 46(1):233-42. PubMed ID: 25338835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.